Skip to main content
. 2023 Aug 14;2(8):pgad261. doi: 10.1093/pnasnexus/pgad261

Fig. 3.

Fig. 3.

Synergistic inhibition of Y1R and MOR is sufficient to induce immunohistochemical and behavioral markers of sensory and affective pain. A) Experimental timeline for PIM, i.t. pharmacology, light brush of the hind paw, and immunohistochemical staining for pERK immunoreactivity in the lumbar DH. B–E) Representative images of ipsilateral DH light-touched evoked pERK immunoreactivity after i.t. administration of agents. F) Intrathecally administered BIB03304:CTOP (10.0 ng) induces light-touched evoked pERK immunoreactivity in the ipsilateral DH. n = 3–4 mice/group. One-way ANOVA: F(3, 11) = 6.749, P = 0.0076; Dunnett's multiple comparison tests. G) Experimental protocol for CPA. H) BIB03304:CTOP (10.0 ng, i.t.) induces CPA in postincision but not postsham incision mice. n = 11–12 mice/group. Two-way ANOVA: interaction F(1, 42) = 4.606, P = 0.0377. Holm–Sidak post hoc test. Data are presented as mean ± SEM.